A new investigation of FDA-approved Alzheimer’s drug donanemab highlights concerns about excess deaths, missing safety data, and financial conflicts of interest among FDA advisory panel members who recommended approval.
A new book by gerontologist Dr Macie Smith aims to provide essential guidance for those caring for loved ones with dementia. The 60-page resource, titled “A Dementia Caregiver Called to Action: The Journey”, addresses common questions and offers insights throughout the caregiving process.
Cambridge scientists question whether recently approved amyloid immunotherapy treatments for Alzheimer’s disease will significantly reduce the condition’s burden, citing concerns about efficacy, safety, and health system challenges.
A groundbreaking study from Finnish researchers uncovers alarming trends in early-onset dementia among working-age adults, with Alzheimer’s disease cases nearly doubling over the past decade.
A groundbreaking MIT study published in Nature offers new insights into the cellular mechanisms underlying Alzheimer’s disease, revealing potential targets for interventions to maintain cognitive function.
Researchers at Boston University have developed an artificial intelligence (AI) model that can predict with 78.5% accuracy whether individuals with mild cognitive impairment will progress to Alzheimer’s-associated dementia over a six-year period.
In a groundbreaking study published in Nature Mental Health [1], researchers from Queen Mary University of London, University College London, and Monash University have unveiled a promising method for the early detection of dementia.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Tsai Lab/ MIT Picower Institute